Chun‐Feng Liu
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 138
- Neurological disorders and treatments 42
- Neuroinflammation and Neurodegeneration Mechanisms 34
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 138
- Neurological disorders and treatments 42
- Neuroinflammation and Neurodegeneration Mechanisms 34
- Biological Psychiatry top 2%
- Biochemistry top 0.5%
-
- Acute Ischemic Stroke Management 38
- Restless Legs Syndrome Research 38
- Autophagy in Disease and Therapy 36
-
- Sleep and Wakefulness Research 30
-
- Advanced ceramic materials synthesis 24
- Cited by
- NeurologyBiological Psychiatry
- Journals
- Journal of the American Chemical Society (1 paper)Nucleic Acids Research (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chun‐Feng Liu
519 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Neurology 1.4k
- Neurology 2.2k
- Biological Psychiatry 250
- Endocrine and Autonomic Systems 548
- Biochemistry 529
Countries citing papers authored by Chun‐Feng Liu
This map shows the geographic impact of Chun‐Feng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Feng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Feng Liu more than expected).
Fields of papers citing papers by Chun‐Feng Liu
This network shows the impact of papers produced by Chun‐Feng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Feng Liu. The network helps show where Chun‐Feng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chun‐Feng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 7 | |
| 3 | 2025 | 0 | |
| 4 | Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic micebreakdown → | 2025 | 16 |
| 5 | 2025 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 18 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 7 | |
| 14 | 2024 | 0 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 6 | |
| 18 | 2018 | 45 | |
| 19 | 2012 | 88 | |
| 20 | 2011 | 56 |
About Chun‐Feng Liu
Chun‐Feng Liu is a scholar working on Neurology, Neurology and Ceramics and Composites, having authored 553 papers that have together received 9.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (138 papers), Neurological disorders and treatments (42 papers), Acute Ischemic Stroke Management (38 papers), Restless Legs Syndrome Research (38 papers), Autophagy in Disease and Therapy (36 papers), Neuroinflammation and Neurodegeneration Mechanisms (34 papers), Sleep and Wakefulness Research (30 papers) and Advanced ceramic materials synthesis (24 papers). The work is most often cited by research in Neurology (1.4k citations), Neurology (2.2k citations) and Biological Psychiatry (250 citations). Chun‐Feng Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Li‐Fang Hu, Fen Wang, Chengjie Mao, Yaping Yang, Yongjun Cao, Shoujiang You, Xingshun Xu, Yanlin Zhang, Yali Wang and Yun Shen. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.